EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Stewardship in Vancomycin-Resistant Enterococcus faecalis: Clinical Study Evaluating Antimicrobial Susceptibility Patterns and Antibacterial Regimens

Samantha A Tolbert iD, Mollie V Day iD, Aline Arif, Preston H Tolbert iD, Destyn Dicharry iD, Alexandre E Malek

Antibiotics · 09.07.2026 · 15 (7) · 672

DOI: 10.3390/antibiotics15070672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.07.2026. Verfasst von Samantha A Tolbert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ochsner LSU Health Shreveport-Academic Medical Center, Shreveport, LA 71103, USA. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vancomycin-resistant enterococci (VRE) Enterococcus faecalis (E. faecalis) remains largely ampicillin-susceptible, yet broad-spectrum agents are frequently used empirically (i.e., daptomycin and linezolid). Despite its frequent susceptibility to ampicillin, VRE E. faecalis is often managed with broad-spectrum antimicrobials, raising concerns about overtreatment and antimicrobial stewardship. Resistance mechanisms vary, with vancomycin resistance mediated by vanA/vanB operons and beta-lactams by altered penicillin binding proteins. These distinct mechanisms help explain why VRE E. faecalis isolates may remain susceptible to ampicillin, supporting its potential use in clinical isolates. This study aims to describe the antibacterial susceptibility results of Enterococcus faecalis VRE and assess antibiotics use in clinical settings in a tertiary medical center.

Methods

This was a single-center, retrospective, descriptive study of hospitalized and outpatient adults with Enterococcus faecalis VRE isolates identified between 1 June 2018 and 15 March 2025. We excluded individuals with concomitant non-Enterococcus faecalis VRE infections and those aged 32 mcg/mL per the 35th edition of the Clinical and Laboratory Standards Institution breakpoints.

Results

A total of 337 patients were screened; 114 met inclusion criteria. The cohort was 54% female, 50% Black, and 48% White, with 54% having hypertension, 36% diabetes, and 19% a history of multidrug-resistant organism carriage. The most common source of infection was urinary (67%), followed by skin and soft tissue infections and bone/joint infections (11% each). All isolates were vancomycin-resistant; 82% were susceptible to ampicillin, 84% to nitrofurantoin, 61% to daptomycin, and 70% to linezolid. Antimicrobial regimens varied, with daptomycin being the most used agent (19%). No patients in the aminopenicillin group experienced 30-day mortality, whereas two patients (3%) in the non-aminopenicillin group died within 30 days. Acute kidney injury occurred in four patients (29%) in the aminopenicillin group compared with four patients (7%) in the non-aminopenicillin group, representing a significantly higher incidence in the aminopenicillin group (p = 0.037). However, myalgia, elevated creatine phosphokinase, and thrombocytopenia were more common in the non-aminopenicillin group.

Conclusions

Despite higher susceptibility to ampicillin and nitrofurantoin, daptomycin was the most used agent for VRE E. faecalis infections. These findings highlight a need for improved antimicrobial stewardship and further clinical studies to guide optimal therapy.

Schlagwörter

Stichwörter der Autor:innen

Enterococcus faecalisampicillin susceptibilityantimicrobial stewardshipvancomycin-resistant enterococci

Autor:innen und Institutionen

  • Ochsner LSU Health Shreveport-Academic Medical Center, Shreveport, LA 71103, USA.
  • Division of Infectious Diseases, Department of Medicine, School of Medicine, LSU Health Shreveport, Shreveport, LA 71103, USA.

ORCID-Profile: Samantha A Tolbert, Mollie V Day, Preston H Tolbert, Destyn Dicharry

Zitieren

APA

Tolbert, S. A., Day, M. V., Arif, A., Tolbert, P. H., Dicharry, D., & Malek, A. E. (2026). Antimicrobial Stewardship in Vancomycin-Resistant Enterococcus faecalis: Clinical Study Evaluating Antimicrobial Susceptibility Patterns and Antibacterial Regimens. Antibiotics, 15(7), 672. https://doi.org/10.3390/antibiotics15070672

Vancouver

Tolbert SA, Day MV, Arif A, Tolbert PH, Dicharry D, Malek AE. Antimicrobial Stewardship in Vancomycin-Resistant Enterococcus faecalis: Clinical Study Evaluating Antimicrobial Susceptibility Patterns and Antibacterial Regimens. Antibiotics. 2026;15(7):672. doi:10.3390/antibiotics15070672

BibTeX
@article{Tolbert2026,
  author = {Tolbert, Samantha A and Day, Mollie V and Arif, Aline and Tolbert, Preston H and Dicharry, Destyn and Malek, Alexandre E},
  title = {Antimicrobial Stewardship in Vancomycin-Resistant Enterococcus faecalis: Clinical Study Evaluating Antimicrobial Susceptibility Patterns and Antibacterial Regimens},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {672},
  doi = {10.3390/antibiotics15070672}
}
Kostenlos starten →